earnings
confidence high
sentiment neutral
materiality 0.75
Illumina Q3 Core revenue $1.08B (-2% YoY); raises FY24 non-GAAP EPS guide to $4.05-$4.15
ILLUMINA, INC.
2024-Q3 EPS reported
-$8.86
revenue$3,268,000,000
- Core Illumina revenue $1.08B, down 2% YoY; GAAP diluted EPS $4.03, non-GAAP $1.14.
- Lowered FY2024 Core revenue guidance to ~3% decline; Q4 revenue expected ~$1.07B.
- Raised FY2024 non-GAAP operating margin guidance to 21%-21.5% and non-GAAP diluted EPS to $4.05-$4.15.
- Free cash flow $284M in Q3, up from $94M YoY; cash & short-term investments $939M.
- Introduced MiSeq i100 Series, FDA approval for TSO Comprehensive, GRAIL spin-off completed June 2024.